Please assess the completion status of the following clinical trial:

Trial Title: Montelukast Added to Standard Therapy for Acute Asthma in Children Age 6-14 Years

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Seeking care in ED for acute asthma exacerbation~* Age 6-14 years inclusive~* Initial FEV1 = 40-70% predicted (defined as moderate severity)~* Consent to participate in study~Exclusion Criteria:~* Severe exacerbation requiring immediate therapy as determined by treating clinician~* Pregnancy by history~* Cystic Fibrosis by history~* Tuberculosis~* Gastroesophageal reflux disease requiring medications~* Acute or chronic liver disease~* Bronchopulmonary dysplasia~* Premature \<34 weeks gestational age by history~* Having used leukotriene-modifying medication within 48 hours~* Having used theophylline within four weeks~* Unable to perform FEV1

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 14 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).